Liver kinase B1 (LKB1) staves off γδ T-cell-mediated autoimmune liver disease

Yiwen Wang,Lan Wu,Luc Van Kaer
DOI: https://doi.org/10.1038/s41423-024-01172-8
2024-05-17
Cellular and Molecular Immunology
Abstract:T lymphocytes expressing γδ T-cell receptors (TCRs) display innate-like effector functions that are preprogrammed during their development in the thymus. This maturation process is regulated by the flow of molecules through various metabolic pathways in a manner that remains incompletely understood. Xiao et al. provided evidence that the metabolic regulator liver kinase B1 (LKB1) promotes the thymic generation of γδ T cells with a balanced effector cytokine production profile that protects the liver from autoimmune attack [1]. γδ T lineage cells play critical roles in host defense against pathogens and in maintaining tissue homeostasis [2]. In sharp contrast to αβ T cells, which acquire their effector functions after antigen encounter in the periphery, many γδ T cells acquire their effector functions during their development in the thymus [3, 4]. Two subsets of preprogrammed γδ T-cell effectors have been identified: interferon (IFN)-γ-producing γδ T (γδT1) cells, which promote pathogen and tumor surveillance, and interleukin (IL)-17-producing γδ T (γδT17) cells, which protect the host from extracellular microorganisms and contribute to the pathogenesis of autoimmune diseases. Understanding the molecular mechanisms that control thymic γδ T-cell effector diversification may offer new therapeutic opportunities for human diseases.
immunology
What problem does this paper attempt to address?